title: Ocular hypotensive effect of ketanserin in patients with primary open angle glaucoma.
authors.affiliation: Institute of Ophthalmology, Chieti.
authors.forename: L
authors.initials: L
authors.lastname: Mastropasqua
authors.forename: C
authors.initials: C
authors.lastname: Costagliola
authors.forename: M
authors.initials: M
authors.lastname: Ciancaglini
authors.forename: P
authors.initials: P
authors.lastname: Carpineto
authors.forename: P E
authors.initials: PE
authors.lastname: Gallenga
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D007650:Ketanserin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D009883:Ophthalmic Solutions; D011680:Pupil / Q000187:drug effects; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D013666:Tears / Q000187:drug effects / Q000378:metabolism; D013999:Timolol / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D012702:Serotonin Antagonists; D013999:Timolol; D007650:Ketanserin